Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

Michael PennickBiosciences Department, Shire Pharmaceutical Development Ltd, Basingstoke, UKAbstract: These studies investigated the absorption and metabolic conversion of lisdexamfetamine dimesylate (LDX), a prodrug stimulant that requires conversion to d-amphetamine for activity. Oral absorption o...

Full description

Bibliographic Details
Main Author:	Michael Pennick
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-06-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/absorption-of-lisdexamfetamine-dimesylate-and-its-enzymatic-conversion-a4556

Similar Items

Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation
by: Matthew D. Lyons MD, et al.
Published: (2017-05-01)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
by: Kristi R. Griffiths, et al.
Published: (2021-08-01)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
by: Jadwiga Najib, et al.
Published: (2017-08-01)

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
by: Weisler Richard, et al.
Published: (2009-08-01)

Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate
by: Guilherme A. Eger, et al.
Published: (2016-03-01)

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
by: Paulo Mattos
Published: (2014-03-01)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
by: Patrick C. Dolder, et al.
Published: (2017-09-01)

Influence of Lisdexamfetamine Dimesylate on Early Ejaculation—Results from a Double-Blind Randomized Clinical Trial
by: Mohammad Haghighi, et al.
Published: (2021-07-01)

Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds
by: Shenghua Gao, et al.
Published: (2018-11-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Traumatic Brain Injury-Related Attention Deficits in Children: A Controlled Treatment Trial with Lisdexamfetamine Dimesylate (Vyvanse)
by: Michael G. Tramontana, et al.
Published: (2021-01-01)

Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol
by: Kristi R. Griffiths, et al.
Published: (2019-07-01)

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
by: Childress Ann C, et al.
Published: (2009-06-01)

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
by: Mattingly Greg W, et al.
Published: (2013-01-01)

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
by: Jain Rakesh, et al.
Published: (2011-11-01)

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
by: Ermer J, et al.
Published: (2013-02-01)

Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
by: L&oacute;pez F, et al.
Published: (2011-05-01)

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
by: Childress Ann C, et al.
Published: (2010-12-01)

Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
by: Sharman J, et al.
Published: (2014-11-01)

Development, validation and comparison of two stability-indicating RP-LC methods using charged aerosol and UV detectors for analysis of lisdexamfetamine dimesylate in capsules
by: Graciela Carlos, et al.
Published: (2016-11-01)

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
by: Coghill DR, et al.
Published: (2014-10-01)

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
by: Weisler RH, et al.
Published: (2013-12-01)

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
by: Gao Joseph, et al.
Published: (2010-06-01)

Lisdexamfetamine Toxicity with Delayed Hypertensive Emergency
by: Rachel Schult, et al.
Published: (2017-12-01)

Update on optimal use of lisdexamfetamine in the treatment of ADHD
by: Madaan V, et al.
Published: (2013-07-01)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
by: Tara Burleigh, et al.
Published: (2020-08-01)

Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
by: Najib J
Published: (2012-05-01)

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
by: Maneeton N, et al.
Published: (2014-10-01)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
by: Gitanjali Srivastava, et al.
Published: (2019-02-01)

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
by: Guerdjikova AI, et al.
Published: (2016-04-01)

amphetamine
by: Song Yeong-Shiuan, et al.
Published: (1999)

Effects of d-amphetamine on the neuromuscular transmission of
by: Ho,Chia-Ching, et al.
Published: (1994)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
by: Diana Domnitei, et al.
Published: (2010-05-01)

Farmakologisk långtidsbehandling vid ADHD : Hur skiljer sig substanserna metylfenidat, lisdexamfetamin och atomoxetin?
by: Andersson, Lea
Published: (2019)

Dangerous Amphetamines
by: Abd Razak, Dzulkifli
Published: (1996)

Effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania
by: Giovana Bristot, et al.
Published: (2019-03-01)

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
by: Adrian Dunlop, et al.
Published: (2021-06-01)

Effects of d-amphetamine on the rat smooth muscles
by: Wu, Nan-Yao, et al.
Published: (1997)

The allosteric interaction of amphetamine with the N-methyl-D-
by: Tsai, Hsiu-Chuan, et al.
Published: (1996)

Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
by: Maneeton B, et al.
Published: (2015-04-01)